Researcher
Karel Fostier
- Keywords:Medicine
- Disciplines:Other translational sciences not elsewhere classified, Other clinical sciences not elsewhere classified, Other basic sciences not elsewhere classified
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Hematology (Department)
Member
From1 Jan 2013 → Today - Hematology (Department)
Member
From1 Feb 2019 → 13 Feb 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 30 Nov 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 2 Dec 2015 - Internal medicine (Department)
Member
From1 Sep 2010 → 31 Dec 2012 - Internal medicine (Department)
Member
From1 Jul 2009 → 31 Aug 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Sep 2006 → 19 Mar 2021
Publications
1 - 10 of 24
- The road to personalized myeloma medicine(2022)
Authors: Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, P Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, et al.
Pages: 159-169 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, Marleen Bakkus
Pages: 599-611 - The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma(2019)
Authors: Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.
- Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway(2019)
Authors: Kim De Veirman, Eline Menu, Ken Maes, Nathan De Beule, Eva De Smedt, Anke Maes, Philip Vlummens, Karel Fostier, Alboukadel Kassambara, Jérôme Moreaux, et al.
Pages: 233-241 - Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition(2018)
Authors: Gil Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Pages: 2156-2158 - Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used(2018)
Authors: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pages: 1815-1818 - Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13(2018)
Authors: An-Sofie Schelpe, Christelle Orlando, Bogaç Ercig, Chloë Geeroms, Inge Pareyn, Nele Vandeputte, Leydi Carolina Velásquez Pereira, Elien Roose, Karel Fostier, Gerry A F Nicolaes, et al.
Pages: 191-199 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Katrijn Broos, Jurgen Corthals, Kris Thielemans, Rik Schots, Brenda De Keersmaecker
Pages: 20476-20489 - Extracellular S100A9 protein in bone marrow supports multiple myeloma survival by stimulating angiogenesis and cytokine secretion(2017)
Authors: Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Pages: 839-846 - Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report(2016)
Authors: Marieke Demeulenaere, Johnny Duerinck, Stephanie Du Four, Karel Fostier, Alex Michotte, Bart Neyns
Pages: 4145-4149